Replicating through telomeres: A means to an end

Trends in Biochemical Sciences

Volumn 40, Issue 9, 2015, Pages 504-515

  Martínez, Paula ^a   Blasco, Maria A ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

G quadruplexes; G strand overhang; Replication; Shelterins; T loop; Telomerase; Telomeres

Indexed keywords

CYCLINE; DNA TOPOISOMERASE (ATP HYDROLYSING); FLAP ENDONUCLEASE; FLAP ENDONUCLEASE 1; MEMBRANE PROTEIN; POT1 INTERACTING PROTEIN 1; PROTECTION OF TELOMERES PROTEIN 1; PROTEIN RTEL1; REPRESSOR ACTIVATOR PROTEIN 1; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 1 INTERACTING PROTEIN 1; TELOMERIC REPEAT BINDING FACTOR 2; UNCLASSIFIED DRUG; DNA; GUANINE QUADRUPLEX; TELOMERASE;

AMINO ACID SEQUENCE; BINDING AFFINITY; CHROMOSOME REPLICATION; DNA DEGRADATION; DNA DETERMINATION; DNA REPAIR; DNA REPLICATION; DNA RNA HYBRIDIZATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TELOMERE; UPREGULATION; ANIMAL; GENETICS; METABOLISM; PHYSIOLOGY;

MAMMALIA;

ANIMALS; DNA; DNA REPLICATION; G-QUADRUPLEXES; HUMANS; TELOMERASE; TELOMERE;

EID: 84939805683     PISSN: 09680004     EISSN: 13624326     Source Type: Journal    
DOI: 10.1016/j.tibs.2015.06.003     Document Type: Review

References (134)

1. van Steensel B., et al. TRF2 protects human telomeres from end-to-end fusions. Cell 1998, 92:401-413.
2. Celli G.B., de Lange T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat. Cell Biol. 2005, 7:712-718.
3. Chin L., et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999, 97:527-538.
4. Karlseder J., et al. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999, 283:1321-1325.
5. Takai H., et al. DNA damage foci at dysfunctional telomeres. Curr. Biol. 2003, 13:1549-1556.
6. Blasco M.A. The epigenetic regulation of mammalian telomeres. Nat. Rev. Genet. 2007, 8:299-309.
7. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005, 19:2100-2110.
8. Palm W., de Lange T. How shelterin protects mammalian telomeres. Annu. Rev. Genet. 2008, 42:301-334.
9. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 2005, 6:611-622.
10. Chai W., et al. Human telomeres have different overhang sizes at leading versus lagging strands. Mol. Cell 2006, 21:427-435.
11. Makarov V.L., et al. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 1997, 88:657-666.
12. Doksani Y., et al. Super-resolution fluorescence imaging of telomeres reveals TRF2-dependent T-loop formation. Cell 2013, 155:345-356.
13. Griffith J.D., et al. Mammalian telomeres end in a large duplex loop. Cell 1999, 97:503-514.
14. Martinez P., Blasco M.A. Role of shelterin in cancer and aging. Aging Cell 2010, 9:653-666.
15. Martinez P., Blasco M.A. Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat. Rev. Cancer 2011, 11:161-176.
16. Chen Y., et al. A shared docking motif in TRF1 and TRF2 used for differential recruitment of telomeric proteins. Science 2008, 319:1092-1096.
17. Lei M., et al. Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection. Nat. Struct. Mol. Biol. 2004, 11:1223-1229.
18. Baumann P., Cech T.R. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 2001, 292:1171-1175.
19. Loayza D., de Lange T. POT1 as a terminal transducer of TRF1 telomere length control. Nature 2003, 423:1013-1018.
20. Wu L., et al. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 2006, 126:49-62.
21. Hockemeyer D., et al. Recent expansion of the telomeric complex in rodents: two distinct POT1 proteins protect mouse telomeres. Cell 2006, 126:63-77.
22. He H., et al. POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination. EMBO J. 2006, 25:5180-5190.
23. Wu P., et al. Telomeric 3' overhangs derive from resection by Exo1 and Apollo and fill-in by POT1b-associated CST. Cell 2012, 150:39-52.
24. Denchi E.L., de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 2007, 448:1068-1071.
25. He H., et al. Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita. Mol. Cell. Biol. 2009, 29:229-240.
26. Hockemeyer D., et al. Engineered telomere degradation models dyskeratosis congenita. Genes Dev. 2008, 22:1773-1785.
27. Kim S.H., et al. TIN2 mediates functions of TRF2 at human telomeres. J. Biol. Chem. 2004, 279:43799-43804.
28. Ye J.Z., et al. POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev. 2004, 18:1649-1654.
29. Takai K.K., et al. Telomere protection by TPP1/POT1 requires tethering to TIN2. Mol. Cell 2011, 44:647-659.
30. Frescas D., de Lange T. TRF2-tethered TIN2 can mediate telomere protection by TPP1/POT1. Mol. Cell. Biol. 2014, 34:1349-1362.
31. Nandakumar J., Cech T.R. Finding the end: recruitment of telomerase to telomeres. Nat. Rev. Mol. Cell Biol. 2013, 14:69-82.
32. Liu D., et al. PTOP interacts with POT1 and regulates its localization to telomeres. Nat. Cell Biol. 2004, 6:673-680.
33. Kibe T., et al. Telomere protection by TPP1 is mediated by POT1a and POT1b. Mol. Cell. Biol. 2010, 30:1059-1066.
34. Chen L.Y., et al. Telomere maintenance through spatial control of telomeric proteins. Mol. Cell. Biol. 2007, 27:5898-5909.
35. Abreu E., et al. TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo. Mol. Cell. Biol. 2010, 30:2971-2982.
36. Tejera A., et al. TPP1 is required for TERT recruitment, telomere elongation during nuclear reprogramming, and normal skin development in mice. Dev. Cell 2010, 18:691-702.
37. Xin H., et al. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 2007, 445:559-562.
38. Li B., de Lange T. Rap1 affects the length and heterogeneity of human telomeres. Mol. Biol. Cell 2003, 14:5060-5068.
39. Li B., et al. Identification of human Rap1: implications for telomere evolution. Cell 2000, 101:471-483.
40. Sfeir A., et al. Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science 2010, 327:1657-1661.
41. Martinez P., et al. Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites. Nat. Cell Biol. 2010, 12:768-780.
42. Sarthy J., et al. Human RAP1 inhibits non-homologous end joining at telomeres. EMBO J. 2009, 28:3390-3399.
43. Martinez P., et al. RAP1 protects from obesity through its extratelomeric role regulating gene expression. Cell Rep. 2013, 3:2059-2074.
44. Yeung F., et al. Nontelomeric role for Rap1 in regulating metabolism and protecting against obesity. Cell Rep. 2013, 3:1847-1856.
45. Yang D., et al. Human telomeric proteins occupy selective interstitial sites. Cell Res. 2011, 21:1013-1027.
46. O'Sullivan R.J., Karlseder J. Telomeres: protecting chromosomes against genome instability. Nat. Rev. Mol. Cell Biol. 2010, 11:171-181.
47. Stewart J.A., et al. Maintaining the end: roles of telomere proteins in end-protection, telomere replication and length regulation. Mutat. Res. 2012, 730:12-19.
48. Olovnikov A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 1973, 41:181-190.
49. Watson J.D. Origin of concatemeric T7 DNA. Nat. New Biol. 1972, 239:197-201.
50. Pellegrini L. The Pol alpha-primase complex. Subcell. Biochem. 2012, 62:157-169.
51. Chow T.T., et al. Early and late steps in telomere overhang processing in normal human cells: the position of the final RNA primer drives telomere shortening. Genes Dev. 2012, 26:1167-1178.
52. Lingner J., et al. Telomerase and DNA end replication: no longer a lagging strand problem?. Science 1995, 269:1533-1534.
53. Huffman K.E., et al. Telomere shortening is proportional to the size of the G-rich telomeric 3'-overhang. J. Biol. Chem. 2000, 275:19719-19722.
54. Flores I., et al. The longest telomeres: a general signature of adult stem cell compartments. Genes Dev. 2008, 22:654-667.
55. Liu L., et al. Telomere lengthening early in development. Nat. Cell Biol. 2007, 9:1436-1441.
56. Marion R.M., et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 2009, 4:141-154.
57. Greider C.W., Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985, 43:405-413.
58. Harley C.B., et al. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
59. Lopez-Otin C., et al. The hallmarks of aging. Cell 2013, 153:1194-1217.
60. Reveal P.M., et al. Synthesis of the mammalian telomere lagging strand in vitro. J. Biol. Chem. 1997, 272:11678-11681.
61. Wang F., et al. Human CST has independent functions during telomere duplex replication and C-strand fill-in. Cell Rep. 2012, 2:1096-1103.
62. Zhao Y., et al. Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells. Cell 2009, 138:463-475.
63. Hemann M.T., et al. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001, 107:67-77.
64. -/- mice with short telomeres. EMBO Rep. 2001, 2:800-807.
65. Bianchi A., Shore D. How telomerase reaches its end: mechanism of telomerase regulation by the telomeric complex. Mol. Cell 2008, 31:153-165.
66. Benetti R., et al. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat. Genet. 2007, 39:243-250.
67. Benetti R., et al. Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination. J. Cell Biol. 2007, 178:925-936.
68. Vera E., et al. Epigenetic regulation of telomeres in human cancer. Oncogene 2008, 27:6817-6833.
69. Garcia-Cao M., et al. Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat. Genet. 2004, 36:94-99.
70. Gonzalo S., et al. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat. Cell Biol. 2006, 8:416-424.
71. Miyake Y., et al. RPA-like mammalian Ctc1-Stn1-Ten1 complex binds to single-stranded DNA and protects telomeres independently of the Pot1 pathway. Mol. Cell 2009, 36:193-206.
72. Surovtseva Y.V., et al. Conserved telomere maintenance component 1 interacts with STN1 and maintains chromosome ends in higher eukaryotes. Mol. Cell 2009, 36:207-218.
73. Goulian M., et al. Purification and properties of an accessory protein for DNA polymerase alpha/primase. J. Biol. Chem. 1990, 265:13221-13230.
74. Casteel D.E., et al. A DNA polymerase-α·primase cofactor with homology to replication protein A-32 regulates DNA replication in mammalian cells. J. Biol. Chem. 2009, 284:5807-5818.
75. Sun J., et al. Stn1-Ten1 is an Rpa2-Rpa3-like complex at telomeres. Genes Dev. 2009, 23:2900-2914.
76. Gelinas A.D., et al. Telomere capping proteins are structurally related to RPA with an additional telomere-specific domain. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:19298-19303.
77. Stewart J.A., et al. Human CST promotes telomere duplex replication and general replication restart after fork stalling. EMBO J. 2012, 31:3537-3549.
78. Gu P., et al. CTC1 deletion results in defective telomere replication, leading to catastrophic telomere loss and stem cell exhaustion. EMBO J. 2012, 31:2309-2321.
79. Chen L.Y., Lingner J. CST for the grand finale of telomere replication. Nucleus 2013, 4:277-282.
80. Huang C., et al. Human Stn1 protects telomere integrity by promoting efficient lagging-strand synthesis at telomeres and mediating C-strand fill-in. Cell Res. 2012, 22:1681-1695.
81. Kasbek C., et al. Human TEN1 maintains telomere integrity and functions in genome-wide replication restart. J. Biol. Chem. 2013, 288:30139-30150.
82. Chen L.Y., et al. The human CST complex is a terminator of telomerase activity. Nature 2012, 488:540-544.
83. Wang F., et al. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 2007, 445:506-510.
84. Gilson E., Geli V. How telomeres are replicated. Nat. Rev. Mol. Cell Biol. 2007, 8:825-838.
85. Oganesian L., Bryan T.M. Physiological relevance of telomeric G-quadruplex formation: a potential drug target. Bioessays 2007, 29:155-165.
86. Pfeiffer V., Lingner J. Replication of telomeres and the regulation of telomerase. Cold Spring Harb. Perspect. Biol. 2013, 5:a010405.
87. Miller K.M., et al. Semi-conservative DNA replication through telomeres requires Taz1. Nature 2006, 440:824-828.
88. Verdun R.E., Karlseder J. The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell 2006, 127:709-720.
89. Martinez P., et al. Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev. 2009, 23:2060-2075.
90. Sfeir A., et al. Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 2009, 138:90-103.
91. d'Alcontres M.S., et al. TopoIIα prevents telomere fragility and formation of ultra thin DNA bridges during mitosis through TRF1-dependent binding to telomeres. Cell Cycle 2014, 13:1463-1481.
92. Beier F., et al. Chronic replicative stress induced by CCL4 in TRF1 knockout mice recapitulates the origin of large liver cell changes. J. Hepatol. 2015, Published online March 27, 2015. 10.1016/j.jhep.2015.03.022.
93. Vannier J.B., et al. RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell 2012, 149:795-806.
94. Lillard-Wetherell K., et al. Association and regulation of the BLM helicase by the telomere proteins TRF1 and TRF2. Hum. Mol. Genet. 2004, 13:1919-1932.
95. Zimmermann M., et al. TRF1 negotiates TTAGGG repeat-associated replication problems by recruiting the BLM helicase and the TPP1/POT1 repressor of ATR signaling. Genes Dev. 2014, 28:2477-2491.
96. Leman A.R., et al. Timeless preserves telomere length by promoting efficient DNA replication through human telomeres. Cell Cycle 2012, 11:2337-2347.
97. Leman A.R., et al. Human Timeless and Tipin stabilize replication forks and facilitate sister-chromatid cohesion. J. Cell Sci. 2010, 123:660-670.
98. Ye J., et al. TRF2 and Apollo cooperate with topoisomerase 2α to protect human telomeres from replicative damage. Cell 2010, 142:230-242.
99. Schneider R.P., et al. TRF1 is a stem cell marker and is essential for the generation of induced pluripotent stem cells. Nat. Commun. 2012, 4:1946.
100. Boue S., et al. Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?. PLoS ONE 2010, 5:e12664.
101. Varela E., et al. Different telomere-length dynamics at the inner cell mass versus established embryonic stem (ES) cells. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:15207-15212.
102. Crabbe L., et al. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 2004, 306:1951-1953.
103. Edwards D.N., et al. Strand exchange of telomeric DNA catalyzed by the Werner syndrome protein (WRN) is specifically stimulated by TRF2. Nucleic Acids Res. 2014, 42:7748-7761.
104. Opresko P.L., et al. Telomere-binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases. J. Biol. Chem. 2002, 277:41110-41119.
105. Edwards D.N., et al. Intramolecular telomeric G-quadruplexes dramatically inhibit DNA synthesis by replicative and translesion polymerases, revealing their potential to lead to genetic change. PLoS ONE 2014, 9:e80664.
106. Barefield C., Karlseder J. The BLM helicase contributes to telomere maintenance through processing of late-replicating intermediate structures. Nucleic Acids Res. 2012, 40:7358-7367.
107. Liu Y., et al. Flap endonuclease 1: a central component of DNA metabolism. Annu. Rev. Biochem. 2004, 73:589-615.
108. Zheng L., et al. Novel function of the flap endonuclease 1 complex in processing stalled DNA replication forks. EMBO Rep. 2005, 6:83-89.
109. Sharma S., et al. WRN helicase and FEN-1 form a complex upon replication arrest and together process branchmigrating DNA structures associated with the replication fork. Mol. Biol. Cell 2004, 15:734-750.
110. Saharia A., et al. Flap endonuclease 1 contributes to telomere stability. Curr. Biol. 2008, 18:496-500.
111. Saharia A., et al. FEN1 ensures telomere stability by facilitating replication fork re-initiation. J. Biol. Chem. 2010, 285:27057-27066.
112. Sharma S., et al. The interaction site of flap endonuclease-1 with WRN helicase suggests a coordination of WRN and PCNA. Nucleic Acids Res. 2005, 33:6769-6781.
113. Ding H., et al. Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell 2004, 117:873-886.
114. Uringa E.J., et al. RTEL1 contributes to DNA replication and repair and telomere maintenance. Mol. Biol. Cell 2012, 23:2782-2792.
115. Sarek G., et al. TRF2 recruits RTEL1 to telomeres in S phase to promote T-loop unwinding. Mol. Cell 2015, 57:622-635.
116. Vannier J.B., et al. RTEL1 is a replisome-associated helicase that promotes telomere and genome-wide replication. Science 2013, 342:239-242.
117. Essers J., et al. Nuclear dynamics of PCNA in DNA replication and repair. Mol. Cell. Biol. 2005, 25:9350-9359.
118. Svendsen J.M., et al. Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell 2009, 138:63-77.
119. Sfeir A.J., et al. Telomere-end processing the terminal nucleotides of human chromosomes. Mol. Cell 2005, 18:131-138.
120. Wu P., et al. Apollo contributes to G overhang maintenance and protects leading-end telomeres. Mol. Cell 2010, 39:606-617.
121. Schaetzlein S., et al. Exonuclease-1 deletion impairs DNA damage signaling and prolongs lifespan of telomere-dysfunctional mice. Cell 2007, 130:863-877.
122. Lam Y.C., et al. SNMIB/Apollo protects leading-strand telomeres against NHEJ-mediated repair. EMBO J. 2010, 29:2230-2241.
123. Deng Y., et al. Multiple roles for MRE11 at uncapped telomeres. Nature 2009, 460:914-918.
124. Leon-Ortiz A.M., et al. Metabolism of DNA secondary structures at the eukaryotic replication fork. DNA Repair (Amst.) 2014, 19:152-162.
125. Tomaska L., et al. Telomeric circles: universal players in telomere maintenance?. Nat. Struct. Mol. Biol. 2009, 16:1010-1015.
126. Wang R.C., et al. Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 2004, 119:355-368.
127. Mitchell J.R., et al. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999, 402:551-555.
128. Armanios M., Blackburn E.H. The telomere syndromes. Nat. Rev. Genet. 2012, 13:693-704.
129. Holohan B., et al. Cell biology of disease: telomeropathies: an emerging spectrum disorder. J. Cell Biol. 2014, 205:289-299.
130. Robles-Espinoza C.D., et al. Telomere-regulating genes and the telomere interactome in familial cancers. Mol. Cancer Res. 2014, 13:211-222.
131. Ramsay A.J., et al. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat. Genet. 2013, 45:526-530.
132. Robles-Espinoza C.D., et al. POT1 loss-of-function variants predispose to familial melanoma. Nat. Genet. 2014, 46:478-481.
133. Shi J., et al. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nat. Genet. 2014, 46:482-486.
134. Bainbridge M.N., et al. Germline mutations in shelterin complex genes are associated with familial glioma. J. Natl. Cancer Inst. 2014, 107:384.